Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJU30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,233
Award facts
- Contract value 100% obligated
- $16,233.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16.2K to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.9M and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal defense and healthcare systems. The company maintains a significant portfolio of federal contracts covering a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current Multaq delivery order supports the Defense Logistics Agency's medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a child contract under the larger SPE2DX vehicle, this award demonstrates AmerisourceBergen's capability to meet federal procurement requirements through open competition and positions it as a key vendor in the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DB25FJU30?
SPE2DB25FJU30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU30 worth?
The government has obligated $16,233 on SPE2DB25FJU30.
Is contract SPE2DB25FJU30 an order under another contract?
Yes. SPE2DB25FJU30 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU30 competed?
The extent of competition for SPE2DB25FJU30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award